GH AMEA’s Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial
Home » GH AMEA’s Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial

GH AMEA on Social Media GH AMEA’s Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial
GH AMEA’s Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial
GH AMEA’s Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial
GH AMEA

Our Chief Medical Officer, Dr. Steve Olsen, sharing his thoughts on the use of the Guardant360 test in the plasmaMATCH trial and how it can help guide treatment decisions for advanced stage breast cancer patients.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us